Alerts
Masks are Required

Wearing masks helps us keep each other safe. Masks are required in our facilities.

If you cannot wear a mask, contact your care team before you visit to discuss telehealth. Patients and visitors not wearing masks will not be permitted to enter.

Skip Navigation
Resources and Core Facilities

Transgenic and Gene Targeting

The Transgenic and Gene Targeting Shared Resource (TGTSR) is an important shared resource providing centralized technical services for the design, production and analysis of genetically engineered rodents and pluripotent stem cells for researchers at The University of Kansas Cancer Center.

The TGTSR has 5 aims:

  1. Provide technical expertise in experimental design for The University of Kansas Cancer Center projects using mice and pluripotent stem cells
  2. Provide technical expertise for design, validation and use of genome editing using CRISPR/Cas9 tools
  3. Provide technical support for genetic alteration of mice and pluripotent stem cells
  4. Provide support for mouse strain development, maintenance and cryopreservation
  5. Educate cancer center researchers and trainees on new and emerging technologies for genetically altered animal models and manipulation of pluripotent stem cells

The complex etiology of tumor development and physiological responses to cancer and cancer therapeutics require the use of animal models. As such, genetically altered mouse models are significant tools for the researchers at the cancer center. The production and analysis of such models ultimately lead to better understanding of biological processes of tumorigenesis, as well as in vivo models for diagnostic testing and cancer treatment.

The TGTSR provides comprehensive services to support the cancer center research related to genetic manipulation of the mouse and stem cell genomes. This shared resource uses front-end technologies, including genome editing via CRISPR/Cas9 tools for genetic manipulation of the mouse in vivo. The TGTSR has dedicated laboratory space for molecular biology, cell culture, embryo manipulation and animal housing for comprehensive support for making and using novel genetically modified mice.

Learn more about the Transgenic and Gene Targeting Institutional Facility.

View the Transgenic and Gene Targeting Brochure.

The TGTSR designed and developed a mouse line for our studies of the role of gene BCL9 in breast cancer. This model allows us to track BCL9-expressing cell lineages and role in tumor development. –Fariba Behbod, PharmD, PhD

Cancer center researcher

Contact us

Scientific director Jay Vivian.

Jay L. Vivian, PhD, Transgenic and Gene Targeting scientific director

Technical director Melissa Larson.

Melissa Larson, PhD, Transgenic and Gene Targeting technical director

Request our services

Engage the Transgenic and Gene Targeting Shared Resource on your project. Email us TGIF@kumc.edu your service request.

Research highlight

Large templates for CRISPR-mediated homology-directed repair

The TGTSR has developed optimal methods for using large double-stranded donor DNA as templates for CRISPR-mediated homology-directed repair (HDR) in vivo.  This system allows for the targeting of large DNA elements to specific regions of the genome. The mouse genetics field is still determining the best methods for performing such CRISPR-mediated manipulations in vivo.  Recent studies using large single-strand DNA templates have shown that such methods result in unacceptably high rates of small undesired deletions. To these ends, the shared resource team has focused its efforts on optimizing the use of long double-strand DNA templates, derived from plasmids, for targeting relatively large DNA elements (200bp-~8kb). These procedural advancements include the use of optimal size of arms of homology and specific preparation methods of the DNA template for injection. These efforts have resulted in a robust, practical, cost-effective and generalizable means of CRISPR-mediated HDR using large double-stranded DNA templates in vivo.

Cite the Cancer Center Support Grant

This resource is funded by The University of Kansas Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (P30 CA168524). Publications that have utilized facility resources, services or scientific data generated by the resource should acknowledge the resource and cite the NCI CCSG grant.

Become a cancer
center member.

Gain access to a network for researchers and members-only grant opportunities. Become a member of The University of Kansas Cancer Center.

Learn more

Related links